XML 21 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1

Accrued Expenses

3 Months Ended

Mar. 31, 2024

Accrued Expenses

Accrued Expenses

5. Accrued Expenses

​

The following is a summary of the Company’s accrued expenses:

​

​	​	​	​	​	​	​
​		March 31,		​	December 31,
​	​	2024		​	2023
Accrued research and development expenses	​	$	1,872,752	​	$	1,824,689
Accrued bonuses	​	​	666,617	​	​	2,561,913
Accrued consulting and other professional fees	​		790,989	​		439,192
Accrued employee benefits	​		566,650	​		399,763
Other accrued expenses	​		10,832	​		—
Accrued expenses	​	$	3,907,840	​	$	5,225,557

​

X

- Definition

The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a),20,24)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration